SECTION 8 | VACCINE ERRORS, SERIOUS ADVERSE EVENTS & EARLY SECOND DOSES Guidance in this section comes from Sections 31.6 & 31.7, and Appendix I of Version 29 of Ministry of Health’s Operating Guidelines for DHBs and Providers: COVID-19 Vaccine Immunisation Programme (tinyurl.com/4b3krr3s).
In the event of a vaccine administration error: 1. Ensure consumer is safe and if still on site ask them to wait in observation area 2. Inform your site lead 3. Contact IMAC on 0800 IMMUNE (466 863) for clinical guidance 4. Inform the consumer/s involved. This should ideally occur at the time, following discussion with site lead and IMAC. i. Apologise, ensure they know how to seek help and are aware of symptoms to be alert for. Give advice on spacing of second dose, arrange follow up call/s with whanau (confirm contact details) ii. Document ‘care plan’ in CIR under notes 5. Record the error in CIR under adverse events error to provide for reporting on vaccine administration errors. See Additional or replacement doses in response to an error (tinyurl.com/25aws645). 6. Complete in house review to determine how the error occurred to provide for strategies to be implemented to prevent a recurrence. 7. Report to the Ministry, refer to Appendix I: CVIP Serious Adverse Event Process (tinyurl.com/4b3krr3s) of MoH Operating Guidelines for DHBs and Providers: COVID-19 Vaccine Immunisation Programme. 8. Ensure vaccine entry in CIR is correct, if necessary correct following CIR guidance. 9. Complete follow up call
IMAC 02/2022
10. Document ‘care plan’ in CIR under notes
COVID-19 IMMUNISATION CLINICAL TOOLKIT | FEBRUARY 2022
CALL 0800 IMMUNE (466 863) FOR CLINICAL ADVICE
11
